FDA approves Tesaro's IV Varubi

Late Wednesday FDA approved Varubi rolapitant IV from Tesaro Inc. (NASDAQ:TSRO) in combination with other antiemetic agents in adults to prevent delayed chemotherapy-induced nausea and vomiting (CINV)...